Roche buys U.S. gene sequencing tech
company Stratos Genomics
Send a link to a friend
[May 22, 2020]
ZURICH (Reuters) - Pharmaceutical
group Roche <ROG.S> has acquired U.S.-based Stratos Genomics to further
develop DNA-based sequencing for diagnostic use, it said on Friday. |
![](../images/052220pics/busine45.jpg)
General view of the Roche building in Welwyn Garden City, following the
outbreak of the coronavirus disease (COVID-19), Welwyn Garden City,
Britain, May 14, 2020. REUTERS/Paul Childs |
"The acquisition provides Roche access to Stratos Genomics
unique chemistry, Sequencing by Expansion," the Swiss drug maker
said in a statement. "The Roche nanopore sequencer, once
developed, will utilise a novel approach that combines
electronic and biological components to sequence DNA for fast,
flexible and cost-effective clinical diagnostic testing."
Financial details of the agreement were not disclosed.
(Reporting by Brenna Hughes Neghaiwi; editing by Thomas Seythal)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
![](column_spacer.png)
|
|
|